Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 71,514 shares at $50.15 ($3.6M) on 2022-03-31, disclosed to the SEC on 2022-04-01.
Open-market sale of $3.6M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.24 | 3,470 | $174K | 4.9% |
| 2 | $50.24 | 3,470 | $174K | 4.9% |
| 3 | $50.24 | 24,381 | $1.2M | 34.1% |
| 4 | $50.24 | 24,381 | $1.2M | 34.1% |
| 5 | $50.15 | 893 | $45K | 1.2% |
| 6 | $50.15 | 6,272 |
| $315K |
| 8.8% |
| 7 | $50.15 | 6,272 | $315K | 8.8% |
| 8 | $50.00 | 296 | $15K | 0.4% |
| 9 | $50.00 | 2,079 | $104K | 2.9% |
| Total | $50.22 avg | 71,514 | $3.6M | 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |